Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Embolism

cetylpyridinium chloride anhydrous has been researched along with Embolism in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's5 (62.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Price, TG1
Maclennan, AH1
Ory, HW1

Other Studies

8 other study(ies) available for cetylpyridinium chloride anhydrous and Embolism

ArticleYear
Preliminary report on maternal deaths in the Southern Highlands of Tanzania in 1983.
    Journal of obstetrics & gynaecology of Eastern and Central Africa, 1984, Volume: 3, Issue:3

    Topics: Abortion, Septic; Africa; Africa South of the Sahara; Africa, Eastern; Cause of Death; Cervix Uteri; Cesarean Section; Delivery of Health Care; Delivery, Obstetric; Demography; Developing Countries; Disease; Embolism; Endometritis; General Surgery; Health; Health Facilities; Health Services; Health Surveys; Hospitals; Infections; Maternal Mortality; Medical Errors; Medicine; Mortality; Obstetric Surgical Procedures; Plants, Medicinal; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy, Ectopic; Pulmonary Embolism; Reproduction; Research; Rural Health Services; Tanzania; Therapeutics; Vascular Diseases

1984
Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contraception Report, 1994, Volume: 5, Issue:1

    Topics: Age Factors; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developed Countries; Disease; Drug Interactions; Economics; Embolism; Family Planning Services; Health; Health Planning Guidelines; Marketing of Health Services; North America; Pharmaceutical Preparations; Population; Population Characteristics; Product Packaging; Public Health; Safety; Therapeutics; Thromboembolism; United States; Vascular Diseases

1994
Oral contraceptives.
    Current therapeutics, 1987, Volume: 28, Issue:12

    Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases

1987
Pill research results in new guidance from CSM.
    Family planning today, 1995

    Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases

1995
Public Prosecutor v. Dr. Nadason Kanagalingam, 9 June 1984.
    Annual review of population law, 1987, Volume: 14

    Topics: Abortion, Induced; Abortion, Therapeutic; Asia; Asia, Southeastern; Crime; Delivery of Health Care; Developing Countries; Disease; Embolism; Family Planning Services; Health; Health Personnel; Jurisprudence; Legislation as Topic; Malaysia; Physicians; Pulmonary Embolism; Social Problems; Vascular Diseases

1987
Epidemiology of venous thromboembolic disease and OC use.
    Dialogues in contraception, 1996,Fall, Volume: 5, Issue:1

    Topics: Bias; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Disease; Embolism; Epidemiology; Family Planning Services; Health; Public Health; Research; Research Design; Risk Factors; Thromboembolism; Vascular Diseases

1996
2 methods for prescribing third-generation OCs.
    Contraceptive technology update, 1997, Volume: 18, Issue:12

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Europe; Family Planning Services; Health; Health Personnel; Health Planning; Health Planning Guidelines; Organization and Administration; Physicians; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases

1997
Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contraceptive technology update, 1997, Volume: 18, Issue:12

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; England; Europe; Family Planning Services; Health; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases

1997